The Ponce Health Sciences University, formerly Ponce School of Medicine & Health Sciences, is a private, for-profit university in Ponce, Puerto Rico. It awards graduate degrees in Medicine, Clinical Psychology, Biomedical Sciences, Medical Sciences, and Public Health.

During the past decade, Ponce Medical School Foundation Inc. conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 3 clinical trials were completed, i.e. on average, 15.8% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 3 clinical trials were completed. i.e. 17.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ponce Medical School Foundation Inc." #1 sponsor was "Eli Lilly and Company" with 10 trials, followed by "Gilead Sciences" with 2 trials sponsored, "Ponce Medical School Foundation, Inc." with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "ModernaTX, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ponce Medical School Foundation Inc." #1 collaborator was "DHR Health Institute for Research and Development" with 1 trials as a collaborator, "Duke University" with 1 trials as a collaborator, "Harvard School of Public Health (HSPH)" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "University of Oxford" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Ponce Medical School Foundation Inc." are "Diabetic Peripheral Neuropathic Pain" (3 trials), "Chronic Low-back Pain" (2 trials), "Osteoarthritis" (2 trials), "Triple Negative Breast Cancer" (2 trials) and "Arthritis, Rheumatoid" (1 trials). Many other conditions were trialed in "Ponce Medical School Foundation Inc." in a lesser frequency.

Most popular intervention types in "Ponce Medical School Foundation Inc." are "Drug" (15 trials), "Biological" (3 trials), "Other" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "LY3556050" (3 trials), "Carboplatin" (2 trials), "Gemcitabine" (2 trials) and "LY3526318" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ponce Medical School Foundation Inc." are 18 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ponce Medical School Foundation Inc.". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Ponce Medical School Foundation Inc., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ponce Medical School Foundation Inc., 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".